BioCorRx Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
715.00
1,170.90
924.70
701.80
657.30
376.70
Cost of Goods Sold (COGS) incl. D&A
295.70
356.50
277.00
205.70
357.50
178.30
Gross Income
419.30
814.50
647.70
496.10
299.80
198.40
SG&A Expense
2,919.60
3,867.00
2,125.90
2,545.30
3,190.70
4,574.40
EBIT
2,500.40
3,052.60
1,478.20
-
2,890.90
4,376
Unusual Expense
1,026.20
277.60
2,810.70
2,806.80
15,666.20
249.20
Interest Expense
310.40
352.80
377.10
1,048.00
11,148.50
1,959.20
Pretax Income
3,836.90
3,127.80
4,666.00
5,904.00
29,705.70
6,584.40
Income Tax
1.60
-
-
-
-
-
Consolidated Net Income
3,838.50
3,127.80
4,666.00
5,904.00
29,705.70
6,584.40
Net Income
3,838.50
3,127.80
4,666.00
5,904.00
29,705.70
6,511.90
Net Income After Extraordinaries
3,838.50
3,127.80
4,666.00
5,904.00
29,705.70
6,511.90
Net Income Available to Common
3,838.50
3,127.80
4,666.00
5,904.00
29,705.70
6,511.90
EPS (Basic)
0.03
0.02
0.03
0.03
0.13
2.60
Basic Shares Outstanding
117,381.70
138,876.80
155,487.60
170,246.00
232,678.60
2,506.20
EPS (Diluted)
0.03
0.02
0.03
0.03
0.13
2.60
Diluted Shares Outstanding
117,381.70
138,876.80
155,487.60
170,246.00
232,678.60
2,506.20
EBITDA
2,364.90
2,917.10
1,353.10
2,019.00
2,857.00
4,368.70
About BioCorRx
View Profile
